Invention Grant
- Patent Title: 1,3-Oxazole compounds for the treatment of cancer
- Patent Title (中): 用于治疗癌症的1,3-恶唑化合物
-
Application No.: US10530810Application Date: 2003-10-10
-
Publication No.: US07189712B2Publication Date: 2007-03-13
- Inventor: Matthew Lee Brown , Mui Cheung , Scott Howard Dickerson , Cassandra Gauthier , Philip Anthony Harris , Robert Neil Hunter , Gregory Pacofsky , Michael Robert Peel , Jeffrey Alan Stafford
- Applicant: Matthew Lee Brown , Mui Cheung , Scott Howard Dickerson , Cassandra Gauthier , Philip Anthony Harris , Robert Neil Hunter , Gregory Pacofsky , Michael Robert Peel , Jeffrey Alan Stafford
- Applicant Address: US PA Philadelphia
- Assignee: SmithKline Beecham Corporation
- Current Assignee: SmithKline Beecham Corporation
- Current Assignee Address: US PA Philadelphia
- Agent John L. Lemanowicz; Jennifer L. Fox
- International Application: PCT/US03/33317 WO 20031010
- International Announcement: WO2004/032882 WO 20040422
- Main IPC: A61K31/541
- IPC: A61K31/541 ; A61K31/5355 ; A61K31/496 ; A61K31/4525 ; A61K31/443 ; A61K31/421 ; C07D417/10 ; C07D413/10
Abstract:
Oxazole derivatives, which are useful as VEGFR2, CDK2, and CDK4 inhibitors are described herein. The described invention also includes methods of making such oxazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Public/Granted literature
- US20050288515A1 Chemical compounds Public/Granted day:2005-12-29
Information query
